{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:56:55Z","timestamp":1775843815865,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015285","name":"Hebei Province Medical Science Research Key Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejphar.2025.178415","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:37:50Z","timestamp":1764261470000},"page":"178415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhibition of Methyltransferase DOT1L alleviates anti-tuberculosis drug-induced liver injury by inhibiting p53-Bax\/Bcl-2 pathway"],"prefix":"10.1016","volume":"1010","author":[{"given":"Li","family":"Jinfeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Shengfei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Dongxue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Yifei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Qirong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Fumin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178415_bib1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.178415_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000502632","article-title":"Resveratrol pretreatment ameliorates p53-Bax axis and augments the survival biomarker B-Cell lymphoma 2 modulated by paracetamol overdose in a rat model of acute liver injury","volume":"105","author":"Al Humayed","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2025.178415_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12935-022-02740-6","article-title":"Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer","volume":"22","author":"Alexandrova","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2025.178415_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/cdd.2014.199","article-title":"DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation","volume":"23","author":"Cattaneo","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2025.178415_bib5","first-page":"1594","article-title":"Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview","volume":"25","author":"Charidemou","year":"2023","journal-title":"Clin. Transl. Oncol. Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex."},{"key":"10.1016\/j.ejphar.2025.178415_bib6","article-title":"Study on the mechanism of hsa_circ_0074763 regulating the miR-3667-3P\/ACSL4 axis in liver fibrosis","volume":"15","author":"Cheng","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178415_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107698","article-title":"Targeting histone methylation and demethylation for non-alcoholic fatty liver disease","volume":"151","author":"Du","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejphar.2025.178415_bib8","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood-2010-03-276501","article-title":"Early mammalian erythropoiesis requires the Dot1L methyltransferase","volume":"116","author":"Feng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2025.178415_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112023","article-title":"Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library","volume":"189","author":"Gibbons","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178415_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41417-020-00261-w","article-title":"Involvement of CDK11B-mediated SPDEF ubiquitination and SPDEF-mediated microRNA-448 activation in the oncogenicity and self-renewal of hepatocellular carcinoma stem cells","volume":"28","author":"Guo","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejphar.2025.178415_bib11","article-title":"Antitumor activity of selenopsammaplin A analog (SPA-10091-HCl) via histone methyltransferase DOT1L degradation and apoptosis induction in castration-resistant prostate cancer cells","volume":"205","author":"Han","year":"2025","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2025.178415_bib12","article-title":"DOT1L suppressed the proliferation of osteosarcoma cell line via modulating SYK\/EGFR\/P53 and SHP2-induced STING-NLRP3-pyroptosis signaling","volume":"15","author":"Hu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178415_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5152\/tjg.2014.4231","article-title":"Acute liver failure in Turkey: a systematic review","volume":"25","author":"Kayaalp","year":"2014","journal-title":"Turk. J. Gastroenterol. Off. J. Turk. Soc. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.178415_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385319","article-title":"An emerging maestro of immune regulation: how DOT1L orchestrates the harmonies of the immune system","volume":"15","author":"Kealy","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178415_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/0008-5472.CAN-24-3304","article-title":"DOT1L mediates stem cell maintenance and represents a therapeutic vulnerability in cancer","volume":"85","author":"Kurani","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178415_bib36","doi-asserted-by":"crossref","first-page":"15299","DOI":"10.1002\/jcp.28175","article-title":"Regulation of P300 and HDAC1 on endoplasmic reticulum stress in isoniazid-induced HL-7702 hepatocyte injury","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2025.178415_bib37","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jcmm.17157","article-title":"Screening differential circular RNA expression profiles reveals the regulatory role of circMARS in anti-tuberculosis drug-induced liver injury","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.178415_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/1751-2980.13205","article-title":"Mapping the incidence of drug-induced liver injury: a systematic review and meta-analysis","volume":"24","author":"Li","year":"2023","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.ejphar.2025.178415_bib17","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.7150\/thno.39013","article-title":"CBP mediated DOT1L acetylation confers DOT1L stability and promotes cancer metastasis","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2025.178415_bib18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4161\/epi.21113","article-title":"Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing","volume":"7","author":"Lu","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.ejphar.2025.178415_bib19","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1021\/acs.jmedchem.5c01587","article-title":"Synthesis, structure-activity relationships, and antitumor activities of Quinoxiline-Containing inhibitors of the protein-protein interactions between transcription coactivator AF9\/ENL and DOT1L\/AF4","volume":"68","author":"Mishra","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178415_bib20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","article-title":"Epigenetics in hepatocellular carcinoma","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2025.178415_bib21","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/cid\/ciz732","volume":"70","author":"Naidoo","year":"2020","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.ejphar.2025.178415_bib22","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1038\/s41467-023-43940-6","article-title":"The Mycobacterium tuberculosis methyltransferase Rv2067c manipulates host epigenetic programming to promote its own survival","volume":"14","author":"Singh","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178415_bib23","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193515","article-title":"The role of DOT1L in the proliferation and prognosis of gastric cancer","volume":"40","author":"Song","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2025.178415_bib24","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","article-title":"The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia","volume":"131","author":"Stein","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2025.178415_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s43556-023-00161-z","article-title":"The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases","volume":"5","author":"Tao","year":"2024","journal-title":"Mol. Biomed"},{"key":"10.1016\/j.ejphar.2025.178415_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131793","article-title":"The hsa_circ_0082152 maintains NF-\u03baB mRNA stability by binding to MTDH to promote anti-tuberculosis drug-induced liver injury","volume":"269","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2025.178415_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/biom8010011","article-title":"DOT1L and H3K79 methylation in transcription and genomic stability","volume":"8","author":"Wood","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2025.178415_bib27","first-page":"425","article-title":"The emerging role of DOT1L in cell proliferation and differentiation: friend or foe","volume":"39","author":"Wu","year":"2024","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ejphar.2025.178415_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","article-title":"Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.178415_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102691","article-title":"STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome","volume":"62","author":"Xiao","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2025.178415_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jcmgh.2021.01.013","article-title":"Inhibition of Dot1L alleviates fulminant hepatitis through myeloid-derived suppressor cells","volume":"12","author":"Yang","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.178415_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109018","article-title":"Hsa_circ_0093884 bound to RNA-binding protein RPS3 ameliorates hepatocyte inflammation in anti-tuberculosis drug-induced liver injury by competitively activating SIRT1","volume":"110","author":"Yang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.178415_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymthe.2022.09.019","article-title":"Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma","volume":"31","author":"Yang","year":"2023","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther"},{"key":"10.1016\/j.ejphar.2025.178415_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-022-01251-1","article-title":"Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias","volume":"15","author":"Yi","year":"2022","journal-title":"J. Hematol. Oncol.J Hematol Oncol"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:05:02Z","timestamp":1773849902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":36,"alternative-id":["S0014299925011690"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178415","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Methyltransferase DOT1L alleviates anti-tuberculosis drug-induced liver injury by inhibiting p53-Bax\/Bcl-2 pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178415"}}